Business · 27/05/1997
FDA Approves New Animal Drug for Heartworm Prevention and Control
The US Food and Drug Administration (FDA) has approved a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. for the use of milbemycin oxime/lufenuron tablets to prevent heartworm disease and control various parasites in dogs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →